Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessStocksGranules India shares gain 2% on USFDA nod for Methocarbamol tablets

    Granules India shares gain 2% on USFDA nod for Methocarbamol tablets

    The US Food & Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) filed by company for Methocarbamol tablet 500 mg and 750 mg.

    Moneycontrol News
    May 08, 2018 / 10:09 IST
    Aurobindo Pharma Ltd.
       
       
      26 Aug, 2025 12:21
      Volume
      Todays L/H
      More

      Shares of Granules India gained 2 percent in the early trade on Tuesday as company received USFDA nod for Methocarbamol tablets.

      The US Food & Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) filed by company for Methocarbamol tablet 500 mg and 750 mg.

      The approved ANDA is the bioequivalent and therapeutically equivalent to reference listed drug (RLD) of Robaxin 500 mg and 750 mg of Auxilium Pharmaceuticals, LLC.

      The company intends to commercialise this product shortly.

      At 09:30 hrs Granules India was quoting at Rs 101.35, up Re 1, or 1 percent on the BSE.

      Posted by Rakesh Patil

      Moneycontrol News
      first published: May 8, 2018 09:37 am

      Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

      Subscribe to Tech Newsletters

      • On Saturdays

        Find the best of Al News in one place, specially curated for you every weekend.

      • Daily-Weekdays

        Stay on top of the latest tech trends and biggest startup news.

      Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347